These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9057024)

  • 1. The role of the S-1 and B-oligomer components of pertussis toxin in its adjuvant properties for Th1 and Th2 cells.
    Ryan MS; Griffin F; Mahon B; Mills KH
    Biochem Soc Trans; 1997 Feb; 25(1):126S. PubMed ID: 9057024
    [No Abstract]   [Full Text] [Related]  

  • 2. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28.
    Ryan M; McCarthy L; Rappuoli R; Mahon BP; Mills KH
    Int Immunol; 1998 May; 10(5):651-62. PubMed ID: 9645613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of chosen parameters of immuno response in mice immunized with whole-cell or acellular pertussis vaccines and challenged with B. pertussis strains harbouring different ptxS1/prn allele genes combinations].
    Gzyl A; Augustynowicz E; Zawadka M; Rabczenko D; Slusarczyk J
    Med Dosw Mikrobiol; 2007; 59(2):137-47. PubMed ID: 17929411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses.
    Mascart F; Verscheure V; Malfroot A; Hainaut M; Piérard D; Temerman S; Peltier A; Debrie AS; Levy J; Del Giudice G; Locht C
    J Immunol; 2003 Feb; 170(3):1504-9. PubMed ID: 12538714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of multi-epitope specificity in memory CD4(+) T cell responses to B. pertussis with age.
    Han WG; van Twillert I; Poelen MC; Helm K; van de Kassteele J; Verheij TJ; Versteegh FG; Boog CJ; van Els CA
    PLoS One; 2013; 8(12):e83583. PubMed ID: 24391789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0.
    Barnard A; Mahon BP; Watkins J; Redhead K; Mills KH
    Immunology; 1996 Mar; 87(3):372-80. PubMed ID: 8778021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular immune response to Bordetella pertussis in two children with whooping cough.
    Hafler JP; Pohl-Koppe A
    Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
    Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bordetella pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice.
    Ryan M; Gothefors L; Storsaeter J; Mills KH
    Dev Biol Stand; 1997; 89():297-305. PubMed ID: 9272363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells.
    Byrne P; McGuirk P; Todryk S; Mills KH
    Eur J Immunol; 2004 Sep; 34(9):2579-88. PubMed ID: 15307190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant and immunogenic activities of the 73kDa N-terminal alpha-domain of BrkA autotransporter and Cpn60/60kDa chaperonin of Bordetella pertussis.
    Cainelli Gebara VC; Risoléo L; Lopes AP; Ferreira VR; Quintilio W; Lépine F; Silva WD; Raw I
    Vaccine; 2007 Jan; 25(4):621-9. PubMed ID: 17011680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes.
    Gaillard ME; Bottero D; Errea A; Ormazábal M; Zurita ME; Moreno G; Rumbo M; Castuma C; Bartel E; Flores D; van der Ley P; van der Ark A; F Hozbor D
    Vaccine; 2014 Feb; 32(8):931-7. PubMed ID: 24397896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of immunity to the respiratory pathogen Bordetella pertussis in normal and gene knockout mice: clearance of primary infection is not enhanced by therapeutic interleukin-12.
    Mahon BP; Ryan M; Griffin F; Mills KH
    Biochem Soc Trans; 1997 May; 25(2):341S. PubMed ID: 9191386
    [No Abstract]   [Full Text] [Related]  

  • 14. Pertussis infection and vaccination induces Th1 cells.
    Brady MT; Mahon BP; Mills KH
    Immunol Today; 1998 Nov; 19(11):534. PubMed ID: 9818551
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathogenetic significance of Bordetella pertussis toxin].
    Finger H
    Immun Infekt; 1985 Apr; 13(2):47-9. PubMed ID: 2860059
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice.
    Orr B; Douce G; Baillie S; Parton R; Coote J
    Vaccine; 2007 Jan; 25(1):64-71. PubMed ID: 16916566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum antibodies against a 69-kilodalton outer-membrane protein, pertactin, from Bordetella pertussis in nonvaccinated children with and without a history of clinical pertussis.
    Trollfors B; Zackrisson G; Taranger J; Lagergård T
    J Pediatr; 1992 Jun; 120(6):924-6. PubMed ID: 1593352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Native and genetically inactivated pertussis toxins induce human dendritic cell maturation and synergize with lipopolysaccharide in promoting T helper type 1 responses.
    Ausiello CM; Fedele G; Urbani F; Lande R; Di Carlo B; Cassone A
    J Infect Dis; 2002 Aug; 186(3):351-60. PubMed ID: 12134231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bordetella pertussis, Finland and France.
    Caro V; Elomaa A; Brun D; Mertsola J; He Q; Guiso N
    Emerg Infect Dis; 2006 Jun; 12(6):987-9. PubMed ID: 16707058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo peptide-MHC II tetramer analysis reveals distinct end-differentiation patterns of human pertussis-specific CD4(+) T cells following clinical infection.
    Han WG; Helm K; Poelen MM; Otten HG; van Els CA
    Clin Immunol; 2015 Apr; 157(2):205-15. PubMed ID: 25728491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.